Publications by authors named "Aurelie Manchuelle"
Article Synopsis
- A study examined the impact of the COVID-19 pandemic on hospital admissions for myocardial infarction (MI) in two French provinces, revealing a significant decline in MI cases during the lockdown period.
- In "Hauts-de-France," there was a 23% decrease in MI incidences, while "Pays-de-la-Loire" saw a 19% decline, both correlating to the number of COVID-19-related deaths in each region.
- The findings indicate that the pandemic's response may have negatively affected cardiovascular health, emphasizing the need for careful communication strategies in crisis situations.
Background: Systems of care have been challenged to control progression of the COVID-19 pandemic. Whether this has been associated with delayed reperfusion and worse outcomes in French patients with ST-segment elevation myocardial infarction (STEMI) is unknown.
Aim: To compare the rate of STEMI admissions, treatment delays, and outcomes between the first peak of the COVID-19 pandemic in France and the equivalent period in 2019.
Axillary Transcatheter Aortic Valve Replacement in Patients With Peripheral Vascular Disease.
Semin Thorac Cardiovasc Surg
December 2019
The axillary artery seems an interesting alternative in nonfemoral transaortic valve replacement (TAVR) patients. This study describes our experience with this technique and its short-term follow-up results. This is a retrospective single center study.
View Article and Find Full Text PDFBackground: Coronary artery disease (CAD) is the leading cause of systolic heart failure (HF). Cardiac magnetic resonance imaging (CMR) is a non-invasive technique that detects a myocardial infarction scar as subendocardial or transmural late gadolinium enhancement (st-LGE).
Aim: We sought to evaluate whether a lack of st-LGE could rule out CAD in new-onset systolic HF of unknown aetiology.
Background: Postprocedural aortic regurgitation occurs in 10 to 20% of patients undergoing transcatheter aortic-valve replacement (TAVR) for aortic stenosis. We hypothesized that assessment of defects in high-molecular-weight (HMW) multimers of von Willebrand factor or point-of-care assessment of hemostasis could be used to monitor aortic regurgitation during TAVR.
Methods: We enrolled 183 patients undergoing TAVR.
Background: The ideal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) is under debate. Lesion length is a well-recognized predictor of PCI complexity and long-term outcome.
Aim: To evaluate the determinants and impact on outcome of long-term DAPT in a retrospective cohort of patients treated for a long coronary lesion.